399 filings
Page 6 of 20
8-K
yzzpul 9mpf4u8
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:29pm
144
xeuj7xg4
5 Jun 23
Notice of proposed sale of securities
8:52pm
4
4vmdplck3jdtrxxe
5 Jun 23
Cerevel Therapeutics / Susan ALTSCHULLER ownership change
8:15pm
4
i9s8hr8mq 9t26l
5 Jun 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
8:12pm
4
mnkp4cbeupcu4kmn4
5 Jun 23
Cerevel Therapeutics / Mark Bodenrader ownership change
8:07pm
144
heb2ux5
1 Jun 23
Notice of proposed sale of securities
4:19pm
3
84jckaxcdrozp
19 May 23
Cerevel Therapeutics / Susan ALTSCHULLER ownership change
4:15pm
10-K/A
37cxr09vfql2ishtb4
19 May 23
Annual report (amended)
4:01pm
8-K
lo1hq g0pkfqd
10 May 23
Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer
6:54am
144/A
dw81 k52f51x
8 May 23
Notice of proposed sale of securities (amended)
7:03pm
144
j1qx0b8sp9lm sft
8 May 23
Notice of proposed sale of securities
4:40pm
4
sctt q06x23qtut
8 May 23
Cerevel Therapeutics / N ANTHONY COLES ownership change
4:24pm
144
94axe
5 May 23
Notice of proposed sale of securities
3:15pm
144
3ssbu9lsn ywup4q8
4 May 23
Notice of proposed sale of securities
2:50pm
144
eys4zoqifi2
4 May 23
Notice of proposed sale of securities
12:00am
8-K
m8lb0hsp
3 May 23
Cerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results
6:39am
ARS
3yqq73 8dhz
28 Apr 23
Annual report to shareholders
4:35pm
DEFA14A
70k26dg 7popzc
28 Apr 23
Additional proxy soliciting materials
4:20pm